Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Rep. Cherfilus-McCormick faces new ethics questions following the release of a report calling for a probe into an earmark she obtained for a nonprofit.

More ethics problems for Democrat Cherfilus-McCormick

Rep. Sheila Cherfilus-McCormick (D-Fla.) is facing new ethics questions following the release of a report by the Office of Congressional Conduct calling for a full-scale probe into an earmark she obtained for a Florida nonprofit, among other allegations.

The House Ethics Committee released a statement on Thursday stating that it had received a referral from OCC one year ago regarding the earmark, which may have ended up going to a for-profit entity in violation of House rules, according to the independent watchdog. The Ethics Committee was required to release the OCC report after one year if the matter hadn’t been resolved.

OCC also looked into whether the third-term Florida Democrat “may have accepted campaign contributions linked to an official action”; “may have dispensed special favors or privileges to friends in connection with her congressional office’s requests for community project funding”; Cherfilus-McCormick’s campaign “may have misreported the source of campaign contribution or accepted a campaign contribution made by one person in the name of another”; and other issues.

The independent ethics watchdog voted unanimously to send the case onto the Ethics Committee.

In a statement, Cherfilus-McCormick noted “The Committee on Ethics has not yet concluded its review of the allegations, and no decision has been made at this time.”

Cherfilus-McCormick – like a lot of members these days – didn’t cooperate with OCC investigators.

The Florida Democrat has been the target of a special investigative subcommittee probe since December 2023 following a previous OCC referral over alleged campaign finance violations. These new allegations will also be reviewed by the special subcommittee.

The earmark in question in this latest case was for $5 million in FY 2023 directed to the Figgers Tablets for Telemedicine, which comes under the aegis of the Figgers Foundation, a Florida non-profit.

The funding was to “support the manufacture and distribution of 15,000 enhanced telehealth enabled tablet computers to low-income senior citizens, particularly senior veterans, and families of children with disabilities in Florida’s 20th United States Congressional District,” according to Cherfilus-McCormick’s letter to the House Appropriations Committee.

In the second half of 2023, three members of the Figgers family donated nearly $20,000 to Cherfilus-McCormick’s campaign, according to FEC records.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.